Viewing nowEsome Tablet 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
DaeHwa Pharmaceutical Co., Ltd.

MFDS item code 201603652 · Approved 2016.06.21 · Insurance code 645604780
Treatment of acid-related disorders and gastrointestinal symptoms; treatment of ulcers and prevention of recurrence and rebleeding; suppression of Helicobacter pylori
This medication is effective for the treatment and prevention of gastroesophageal reflux disease and erosive esophagitis, as well as for the alleviation of symptoms caused by reflux disease. It is also helpful in treating and preventing recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It is effective in alleviating symptoms such as pain, discomfort, and burning sensation that may occur with the use of non-steroidal anti-inflammatory drugs and supports the treatment and prevention of associated gastric and duodenal ulcers. Additionally, it is used for the treatment of Zollinger-Ellison syndrome and for the prevention and maintenance therapy for gastric or duodenal ulcer rebleeding. This medication helps improve and treat gastrointestinal diseases overall.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent episodes of symptoms can be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. Administer 20 mg of this medicine with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. The treatment period is 4 to 8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 to 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. After initiation of intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers, administer 40 mg once daily for 4 weeks. No dose adjustment is necessary. This medicine should be administered with caution because there is limited experience in patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Adolescents 12 years of age and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years of age and older — Once symptoms have resolved, subsequent episodes of symptoms can be controlled by administering 20 mg once daily. Adolescents 12 years of age and older — In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. Children under 12 years of age — There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients with an allergy to this medication or its components, or those who have previously experienced hypersensitivity reactions to benzimidazole derivatives should not use it. Additionally, when used in combination with penicillin antibiotics or macrolide antibiotics for the treatment of Helicobacter pylori infection, patients allergic to those antibiotics should also avoid taking this medication. This medication may cause serious side effects when used in combination with certain heart-related medications, so it should not be administered to patients taking terfenadine, cisapride, pizotifen, or astemizole. Moreover, it is also advisable for patients taking certain antiviral drugs like atazanavir and nelfinavir, as well as nursing mothers, to avoid using this medication. Patients with a history of myocardial infarction or those taking rilpivirine containing products should also not be administered this medication. This medication may cause various adverse reactions, with the most common symptoms being headache, abdominal pain, diarrhea, constipation, nausea, and vomiting. Rarely, serious side effects may occur, including blood-related problems, allergic reactions, hypomagnesemia, psychiatric symptoms, liver function abnormalities, skin rashes, myalgia, and nephritis, so if symptoms appear, you should consult a doctor immediately. Regular check-ups are necessary during long-term use, and care should be taken especially if used for more than one year as the risk of hypomagnesemia and fractures may increase. This medication suppresses gastric acid secretion which may promote bacterial growth in the stomach, slightly increasing the risk of infection. Additionally, interactions with other medications may occur during use, so if taken with warfarin, digoxin, methotrexate, clopidogrel, etc., monitoring serum concentration changes is essential. The safety of this medication during pregnancy has not been adequately established, so it should be used cautiously based on the doctor's judgment, and it is preferable to avoid use while breastfeeding. In case of overdose, since there are no specific antidotes, you should visit a hospital immediately for symptomatic treatment, and keep it out of reach of children.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, general edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disturbance, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disturbances, pharyngeal disturbances, rectal disturbances, gastrointestinal symptoms, increased serum gastrin levels, tongue disturbances, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, hyponatremia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening of depression, hypertonicity, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, worsening of migraine, sleep disturbances, tremors, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, worsening of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, altered sense of smell, loss of taste, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric foveolar polyp, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature. This will help maintain the medication's effectiveness longer.
Pink round film-coated tablet
14 tablets/blister × 2
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
DaeHwa Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.